Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
10.04
-0.03 (-0.30%)
At close: Jun 13, 2025, 4:00 PM
10.01
-0.03 (-0.30%)
After-hours: Jun 13, 2025, 7:13 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.61 billion as of June 13, 2025. Its market cap has decreased by -50.66% in one year.
Market Cap
2.61B
Enterprise Value
11.02B
1-Year Change
-50.66%
Ranking
Category
Stock Price
$10.04
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.61B, a decrease of -68.99%. That is a compound annual growth rate of -24.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 2.61B | -32.08% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |